Literature DB >> 18283326

The carcinogenic effects of radioiodine therapy for thyroid carcinoma.

Florent de Vathaire1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18283326     DOI： 10.1038/ncpendmet0761

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  8 in total

1.  (131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.

Authors:  Kuan-Yin Ko; Chia-Hung Kao; Cheng-Li Lin; Wen-Sheng Huang; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-22       Impact factor: 9.236

2.  Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.

Authors:  Laura Boucai; John Falcone; Jenny Ukena; Catherine C Coombs; Ahmet Zehir; Ryan Ptashkin; Michael F Berger; Ross L Levine; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 3.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

4.  Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Authors:  N Gopalakrishna Iyer; Luc G T Morris; R Michael Tuttle; Ashok R Shaha; Ian Ganly
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

5.  Therapy-related myeloid neoplasms following treatment with radioiodine.

Authors:  Thomas Schroeder; Andrea Kuendgen; Sabine Kayser; Nicolaus Kröger; Friederike Braulke; Uwe Platzbecker; Viola Klärner; Fabian Zohren; Detlef Haase; Michael Stadler; Richard Schlenk; Akos G Czibere; Ingmar Bruns; Roland Fenk; Norbert Gattermann; Rainer Haas; Guido Kobbe; Ulrich Germing
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

6.  Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.

Authors:  Stéphane Maillard; Francesca Damiola; Enora Clero; Maroulio Pertesi; Nivonirina Robinot; Frédérique Rachédi; Jean-Louis Boissin; Joseph Sebbag; Larrys Shan; Frédérique Bost-Bezeaud; Patrick Petitdidier; Françoise Doyon; Constance Xhaard; Carole Rubino; Hélène Blanché; Vladimir Drozdovitch; Fabienne Lesueur; Florent de Vathaire
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131.

Authors:  Doina Piciu; Claudiu Pestean; Elena Barbus; Maria Iulia Larg; Andra Piciu
Journal:  Clujul Med       Date:  2016-07-28

8.  Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer.

Authors:  Yao Yao; Shuai Cheng; Xinyu Xu; Xinyuan Chen; Wei Chen; Yichun Qian; Yuan Zhang
Journal:  Ann Transl Med       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.